Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
No, the real reason you havent been sued | ignatiusrielly35 | investorshub | 07/20/2024 4:33:27 AM |
With your logic, the courts would be flooded | kund | investorshub | 07/20/2024 4:28:59 AM |
Yes the TOTAL for today 592K shares and | k9uwa | investorshub | 07/20/2024 4:21:55 AM |
lol. You should rather consider yourself lucky that | ignatiusrielly35 | investorshub | 07/20/2024 3:31:56 AM |
Hope DOJ and SEC sue Misleading for his | kund | investorshub | 07/20/2024 3:25:59 AM |
That is a good question. | Steady_T | investorshub | 07/20/2024 1:04:09 AM |
Are you ever gonna stop? | mrplmer | investorshub | 07/20/2024 12:06:06 AM |
maybe even 10 million shares bought.--another great | plexrec | investorshub | 07/19/2024 11:46:52 PM |
Your predictions are worse than a coin toss | frrol | investorshub | 07/19/2024 11:07:03 PM |
Trofinetide for the treatment of Rett syndrome: Long-term | georgejjl | investorshub | 07/19/2024 10:52:32 PM |
That information is not in the clinical trials | Hoskuld | investorshub | 07/19/2024 10:30:50 PM |
Each of the participants in the Anavex OLE | georgejjl | investorshub | 07/19/2024 9:02:31 PM |
Correct me if I'm wrong, doesn't all of | abew4me | investorshub | 07/19/2024 8:52:48 PM |
Was able to dnargle up a few shares | mauismart | investorshub | 07/19/2024 8:31:07 PM |
Lol! That was one hell of short squeeze | Investor2014 | investorshub | 07/19/2024 8:13:09 PM |
Exhibit 11639 | frrol | investorshub | 07/19/2024 8:11:08 PM |
george, you were only 4.3 MILLION SHORT on | powerwalker | investorshub | 07/19/2024 8:10:40 PM |
Well that was some serious short squeeze today | BDR10 | investorshub | 07/19/2024 8:10:12 PM |
Short squeeze on the blood supply to your brain. | poguemahone | investorshub | 07/19/2024 8:08:59 PM |
SHORT SQUEEZE on $AVXL stock!!! | georgejjl | investorshub | 07/19/2024 7:58:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...